Editas Medicine has raised over £77m over recent days to invest in biotechnology research. Its main area is gene editing, which looks into rewriting DNA to remove disorders. It is hoped such research could one day treat deadly diseases by modifying and ‘fixing’ faulty genes, as scientists can use it to correct the human genome and remove malfunctioning parts of the DNA.